Long-acting injectable paliperidone palmitate in a haemodialysis patient with schizophrenia

被引：0
|
作者：
Lin, Jia-Hong [1 ]
Tsai, Tsung-Huang [2 ]
Lee, Chia-Shun [2 ]
Yang, Ya-Hui [2 ]
Chen, Kuang-Peng [2 ]
Tung, Chun-Liong [2 ]
Tsai, Jui-Hsiu [2 ,3 ,4 ]
机构：
[1] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Internal Med, Chiayi, Taiwan
[2] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Psychiat, 2 Min Sheng Rd, Chiayi 622, Taiwan
[3] Natl Hlth Res Inst, PhD Program Environm & Occupat Med, Kaohsiung, Taiwan
[4] Kaohsiung Med Univ, Kaohsiung, Taiwan
来源：
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY | 2021年 / 55卷 / 08期
关键词：
D O I：
10.1177/0004867420952548
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：829 / 830
页数：2
相关论文
共 50 条
  • [21] EFFICACY AND TOLERABILITY OF LONG-ACTING INJECTABLE PALIPERIDONE PALMITATE IN THE TREATMENT OF DUAL PSYCHOSIS
    Vazquez Vazquez, J. M.
    Gonzalez-Rodriguez, A.
    Sanz Asin, P.
    Vicente Perellon, L.
    Lopez Garcia, F. J.
    Cruz Alonso, C.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [22] Is paliperidone palmitate more effective than other long-acting injectable antipsychotics?
    Desai, Mitesh
    Wooller, Annette
    Lignugaris, Arunas
    Gopal, Srihari
    PSYCHOLOGICAL MEDICINE, 2018, 48 (12) : 2098 - 2099
  • [23] COST OF LONG-ACTING RISPERIDONE INJECTION VERSUS LONG-ACTING PALIPERIDONE PALMITATE IN PATIENTS WITH SCHIZOPHRENIA IN RUSSIA
    Omelyanovsky, V
    Avxentyeva, M.
    Ivakhnenko, O.
    Khailov, P.
    Tsfasman, F. M.
    Krysanov, I
    Zorin, N.
    VALUE IN HEALTH, 2012, 15 (07) : A338 - A338
  • [24] Patient satisfaction with 6-month paliperidone palmitate versus other long-acting injectable antipsychotics
    Perez-Balaguer, A.
    Garcia del Castillo, I.
    Gomez-Esteban, B.
    Vicente-Burguillo, M.
    Vizcaino-Herrezuelo, H.
    Castelao-Almodovar, S.
    Arce de la Riva, A.
    Neira-Serrano, F.
    EUROPEAN PSYCHIATRY, 2024, 67 : S726 - S726
  • [25] Effects of Long-acting Injectable 3-Monthly Paliperidone Palmitate on the Clinical and Social Performance of Patients with Schizophrenia
    Oh, Jihoon
    Oh, Jihye
    Kim, Dong Wook
    Youn, HyunChul
    Kim, Sae-Hoon
    Kim, Soo In
    Chung, In Won
    Wang, Kuan Shu
    Kim, Minah
    Paik, Jong -Woo
    Koh, Min Jung
    Lee, Yoosun
    Choi, Seok Young
    Kim, Jung-Jin
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2023, 21 (01) : 126 - 134
  • [26] Effects of Long-Acting Injectable Paliperidone Palmitate on Clinical and Functional Outcomes in Patients With Schizophrenia Based on Illness Duration
    Kim, Seoyoung
    Kim, SuYoun
    Koh, MinJung
    Choi, GumJee
    Kim, Jung-Jin
    Paik, In-Ho
    Kim, Seung-Hyun
    Choi, Yong-Sung
    Lee, Yohan
    Suh, Jaewon
    Takeuchi, Hiroyoshi
    Uchida, Hiroyuki
    Kim, Euitae
    JOURNAL OF CLINICAL PSYCHIATRY, 2021, 82 (01)
  • [27] Paliperidone Palmitate versus Risperidone Long-Acting Injectable in Patients with Schizophrenia: A Meta-Analysis of Efficacy and Safety
    Zhao, Mingjun
    Qin, Bin
    Mao, Yage
    Zhang, Yang
    Zhao, Ruisheng
    Wang, Aiqin
    Wang, Hailing
    Zhao, Jianting
    Wang, Changhong
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2023, 19 : 749 - 757
  • [28] Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia
    Rosenheck, Robert A.
    Leslie, Douglas L.
    Sint, Kyaw J.
    Lin, Haiqun
    Li, Yue
    McEvoy, Joseph P.
    Byerly, Matthew J.
    Hamer, Robert M.
    Swartz, Marvin S.
    Stroup, T. Scott
    PSYCHIATRIC SERVICES, 2016, 67 (10) : 1123 - 1129
  • [29] Economic analysis of paliperidone long-acting injectable for chronic schizophrenia in Portugal
    Einarson, Thomas R.
    Maia-Lopes, Susana
    Goswami, Pushpendra
    Bereza, Basil G.
    Van Impe, Kristel
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (09) : 913 - 921
  • [30] In vitro and in vivo characterization of Invega Sustenna® (paliperidone palmitate long-acting injectable suspension)
    Li, Ji
    Rodriguez, Antonela
    Wang, Kaikai
    Olsen, Karl
    Wang, Yan
    Schwendeman, Anna
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2025, 207
12345